Cytogenetic and molecular analysis of the deletions of chromosome 5 in myeloid disorders.
Le Beau
M M
MM
Department of Medicine, University of Chicago, Illinois 60637.
D000970:Antineoplastic Agents / Q000009:adverse effects; D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D002895:Chromosomes, Human, Pair 5 / Q000648:ultrastructure*; D003115:Colony-Stimulating Factors / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics; D051766:Early Growth Response Protein 1; D008040:Genetic Linkage; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000235:genetics; D006801:Humans; D017874:Immediate-Early Proteins; D007378:Interleukins / Q000235:genetics; D007951:Leukemia, Myeloid / Q000139:chemically induced / Q000235:genetics*; D007953:Leukemia, Radiation-Induced / Q000235:genetics; D009190:Myelodysplastic Syndromes / Q000209:etiology / Q000235:genetics*; D011878:Radiotherapy / Q000009:adverse effects; D014157:Transcription Factors / Q000235:genetics; D014178:Translocation, Genetic
D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors; D004268:DNA-Binding Proteins; C497325:EGR1 protein, human; D051766:Early Growth Response Protein 1; D006133:Growth Substances; D017874:Immediate-Early Proteins; D007378:Interleukins; D014157:Transcription Factors; D016178:Granulocyte-Macrophage Colony-Stimulating Factor